Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Even

Showing results (171-180 of 176) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 176 results.
ESMO Open|March 5, 2026
Phase II study of magrolimab combination therapies in patients with head and neck squamous-cell carcinomaA D Colevas, V Chin, J J Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 16, 2020
Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III studyR L Ferris, R Haddad, C Even, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2022
Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitorsF Peyraud, J-P Guégan, D Bodet, et al.
ESMO Open|May 1, 2025
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)R Galot, C Le Tourneau, L Licitra, et al.
ESMO Open|February 22, 2025
Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-upC Resteghini, B Baujat, P Bossi, et al.
Diabetes|March 12, 2008
Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesityMarcelo A Mori, Ronaldo C Araújo, Felipe C G Reis, et al.
Pageof 18

Showing results (171-180 of 176) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 176 results.
ESMO Open|March 5, 2026
Phase II study of magrolimab combination therapies in patients with head and neck squamous-cell carcinomaA D Colevas, V Chin, J J Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 16, 2020
Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III studyR L Ferris, R Haddad, C Even, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2022
Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitorsF Peyraud, J-P Guégan, D Bodet, et al.
ESMO Open|May 1, 2025
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)R Galot, C Le Tourneau, L Licitra, et al.
ESMO Open|February 22, 2025
Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-upC Resteghini, B Baujat, P Bossi, et al.
Diabetes|March 12, 2008
Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesityMarcelo A Mori, Ronaldo C Araújo, Felipe C G Reis, et al.
Pageof 18